Intestinal and enthesis innate immunity in early axial spondyloarthropathy

Rheumatology (Oxford). 2020 Oct 1;59(Suppl4):iv67-iv78. doi: 10.1093/rheumatology/keaa408.

Abstract

Axial SpA (axSpA), encompassing AS, is a multifactorial disease that localizes to sites of high spinal biomechanical stress. Much has been written on T cells and adaptive immunity in axSpA, which is understandable given the very strong HLA-B27 disease association. Extra-axial disease characteristically involves the anterior uveal tract, aortic root, lung apex and terminal ileum. Under recent classification, axSpA is classified as an intermediate between autoimmunity and autoinflammatory disease, with the latter term being synonymous with innate immune dysregulation. The purpose of this review is to evaluate the 'danger signals' from both the exogenous intestinal microbiotal adjuvants or pathogen-associated molecular patterns that access the circulation and endogenously derived damaged self-tissue or damage-associated molecular patterns derived from entheses and other sites of high biomechanical stress or damage that may serve as key drivers of axSpA onset, evolution, disease flares and eventual outcomes.

Keywords: axial spondyloarthritis (axSpA); damage-associated molecular patterns (DAMPs); danger signals; enthesitis; pathogen-associated molecular patterns (PAMPs).

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Cytokines / metabolism
  • Enthesopathy / etiology*
  • Enthesopathy / immunology
  • Gastrointestinal Microbiome* / immunology
  • Humans
  • Immunity, Innate*
  • Spondylarthritis / etiology*
  • Spondylarthritis / immunology

Substances

  • Cytokines